Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Sees Large Increase in Short Interest

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 590,600 shares, a growth of 60.1% from the August 31st total of 369,000 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 5,906.0 days.

Recordati Industria Chimica e Farmaceutica Stock Performance

RCDTF stock remained flat at $52.25 during trading on Friday. The company has a current ratio of 1.36, a quick ratio of 0.95 and a debt-to-equity ratio of 0.73. The stock’s fifty day moving average price is $52.13 and its two-hundred day moving average price is $51.79. Recordati Industria Chimica e Farmaceutica has a fifty-two week low of $52.25 and a fifty-two week high of $52.25.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) last released its quarterly earnings data on Tuesday, July 30th. The company reported $0.70 earnings per share for the quarter. The firm had revenue of $622.00 million during the quarter. Recordati Industria Chimica e Farmaceutica had a return on equity of 30.78% and a net margin of 17.41%.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.